Form 4 for ACRV Acrivon Therapeutics, Inc.
Accepted 2025-11-18 00:00:00 ET · period of report 2025-11-14 · accession 0000905148-25-004129 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-18 | 2025-11-14 | ACRV | Gamelin Erick | Chief Development Off | F - Tax | $2.24 | -403 | 15.3K | -3% | -$902.72 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-14 | F | D | 403 | $2.24 | 15,283 | D | — | — |